Comera Life Sciences Holdings, Inc.
CMRADelisted Feb 15, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001907685
Comera Life Sciences Holdings, Inc. was delisted on Feb 15, 2024; its insiders filed their last Form 4 on Feb 2, 2024; 14 institutions reported holding it in 13F filings for Q3 2023, worth $194.1K in total; no superinvestor held it.
13F holders, Q1 2023
Institutional positions in Comera Life Sciences Holdings, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 11
- 0 vs. Q4 2022
- Shares held
- 527.3K
- +4.22K (+0.8%) vs. Q4 2022
- Total value
- $189.8K
- −$453.0K (−70.5%) vs. Q4 2022
- New holders
- 0
- 4 more added
- Sold out
- 0
- 2 more reduced
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CMRA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 14 | $194.1K |
| Q2 2023 | 11 | $103.2K |
| Q1 2023 | 11 | $189.8K |
| Q4 2022 | 12 | $642.8K |
| Q3 2022 | 16 | $940.8K |
| Q2 2022 | 10 | $710.0K |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Comera Life Sciences Holdings, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Geode Capital Management, LLC | 60,008 | $53.9K | 0.00% | 00.0% | Unchanged |
| HighTower Advisors, LLC | 47,600 | $43.0K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 44,098 | $39.6K | 0.00% | +100+0.2% | Added |
| State Street Corp | 29,600 | $26.6K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 18,910 | $17.0K | 0.00% | −1,000−5.0% | Reduced |
| Tower Research Capital LLC (TRC) | 5,566 | $5.00K | 0.00% | +4,272+330.1% | Added |
| Morgan Stanley | 2,292 | $2.06K | 0.00% | −3−0.1% | Reduced |
| UBS Group AG | 2,059 | $1.85K | 0.00% | +826+67.0% | Added |
| Wolverine Asset Management LLC | 652 | $586 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 76 | $68 | 0.00% | +24+46.2% | Added |
| Lake Street Advisors Group, LLC | 316,469 | $0 | 0.00% | 00.0% | Unchanged |
| Trustcore Financial Services, LLC | – | – | – | – | Not filed |